Engineered mesenchymal stem cells and method of using same to treat tumors

Details for Australian Patent Application No. 2010237130 (hide)

Owner Apceth GmbH & Co. KG

Inventors Nelson, Peter

Agent Golja Haines & Friend

Pub. Number AU-A-2010237130

PCT Pub. Number WO2010/119039

Priority 61/168,787 13.04.09 US

Filing date 13 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

C12N 5/0775 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal stem cells

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/119039 Priority application(s): WO2010/119039

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010237145-A method and a system for pressurising and dispensing carbonated beverages

2010237125-Petrolatum based composition comprising greater than 10% silicone for improved feel while remaining stable